Sponsor
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
AirTalk

As San Francisco considers supervised drug injection sites, we debate the impact

TO GO WITH AFP STORY by Laurent VU THE, Canada-society-drugs-health
A client of the Insite supervised injection Center in Vancouver, Canada, collects her kit on May 3, 2011. The Canadian Supreme Court is to settle a conflict between the government's wishes to close the center and the center's success in fighting the spread of AIDS among drug addicts. In eight years of existence, and with more 600 visits per day on average, Insite believes it has made advances in the fight against AIDS. And in a radius of 500 meters around the center, deaths by overdose dropped by 35 percent since the opening, according to a study published in the medical newspaper The Lancet.    AFP PHOTO/Laurent Vu The (Photo credit should read Laurent Vu The/AFP/Getty Images)
TO GO WITH AFP STORY by Laurent VU THE, Canada-society-drugs-health A client of the Insite supervised injection Center in Vancouver, Canada, collects her kit on May 3, 2011. The Canadian Supreme Court is to settle a conflict between the government's wishes to close the center and the center's success in fighting the spread of AIDS among drug addicts. In eight years of existence, and with more 600 visits per day on average, Insite believes it has made advances in the fight against AIDS. And in a radius of 500 meters around the center, deaths by overdose dropped by 35 percent since the opening, according to a study published in the medical newspaper The Lancet. AFP PHOTO/Laurent Vu The (Photo credit should read Laurent Vu The/AFP/Getty Images)
(
AFP/AFP/Getty Images
)
Listen 1:36:12
San Francisco announced that it's looking to open two SDI's by August, but how do these facilities operate and what is their impact on the health of drug users? We also check in on how Hawaii is coping with the new fissure eruption in Kilauea; dive into the chaos of tomorrow's royal wedding; and more.
San Francisco announced that it's looking to open two SDI's by August, but how do these facilities operate and what is their impact on the health of drug users? We also check in on how Hawaii is coping with the new fissure eruption in Kilauea; dive into the chaos of tomorrow's royal wedding; and more.

San Francisco announced that it's looking to open two SDI's by August, but how do these facilities operate and what is their impact on the health of drug users? We also check in on how Hawaii is coping with the new fissure eruption in Kilauea; dive into the chaos of tomorrow's royal wedding; and more.

New fissure, toxic ash: the latest from the Kilauea eruption

Listen 7:31
New fissure, toxic ash: the latest from the Kilauea eruption

There’s been a new fissure in the Kilauea volcano, which erupted Thursday in Hawaii.

The newest opening is in Leilani Estates, bringing the total number of fissures to 21. Over two dozen homes have been consumed by lava and authorities have handed out about 2,000 masks, warning locals of sulfur dioxide gas and toxic ash.

We check in with a scientist on the ground in Hawaii for the latest.

Guest:

Wendy Stovall, deputy scientist-in-charge at the U.S.Geological Survey’s Yellowstone Volcano Observatory; she studied Kilauea in Hawaii from 2005-2009

FDA greenlights first preventative migraine drug. How does it work?

Listen 7:58
FDA greenlights first preventative migraine drug. How does it work?

On Thursday, the Food and Drug Administration approved Aimovig, a first-of-its kind drug designed to prevent crippling migraines.

The injection device resembles an insulin pen, and its manufacturers, Amgen and Novartis, expect it to be available for patients within the next week. Three additional companies are also awaiting FDA approval for similar medications.

An estimated 38 million Americans suffer from migraines each year. So what’s new about Aimovig and does it appear to be promising? Will it be cost effective? If you’re a doctor who specializes in treatment for chronic headaches and migraines, what’s your response to the new medication? Call us at 866-893-5722.

Guest:

Nada Hindiyeh, M.D., clinical assistant professor of neurology and neurological sciences at Stanford University’s Headache and Facial Pain Program; she specializes in chronic migraines and treatments for headache disorders

As San Francisco considers supervised drug injection sites, we debate the impact

Listen 13:32
As San Francisco considers supervised drug injection sites, we debate the impact

San Francisco is considering opening the first “supervised injection site” in the nation, a place where addicts can bring their own drugs and inject them under the care of a trained medical staff.

San Francisco workers reportedly collect more than 287,000 syringes from streets and alleys each month. The move aims to reduce the number of overdoses and infections that spread through shared needles.

But skeptics say the city would be enabling drug users. According to a statement by the Drug Enforcement Administration, the plan would violate the Controlled Substances Act (CSA). Anyone using such sites could face prosecution as it would be against federal law. So would supervised injection sites enable drug users or would it help them seek care?

Call us at 866-893-5722.

Guests:

Laura Thomas, acting director of the California chapter of the Drug Policy Alliance, a drug law reform advocacy group; she’s been advocating for the San Francisco injection site for the past decade

Ron Allen, head of the International Faith Based Coalition, a drug prevention group in Sacramento

A check in on the school shooting in Santa Fe, Texas

Listen 4:17
A check in on the school shooting in Santa Fe, Texas

Police are investigating possible explosive devices at Santa Fe High about 30 miles SE of Houston, as well as off campus.

At least eight people were shot and killed at the school this morning. Most were students. One suspect is in custody and another person of interest is being questioned. We check in with a reporter in Houston. 

Guest:

Gail DeLaughter, transportation reporter for Houston Public Media News, the NPR affiliate in Houston

What Prince Harry and Meghan Markle’s wedding says about the modernization of the British monarchy

Listen 14:08
What Prince Harry and Meghan Markle’s wedding says about the modernization of the British monarchy

The royal wedding between Prince Harry and Meghan Markle is finally happening tomorrow.

American fascination with the royal family isn’t new. But this wedding, you can argue, is particularly relevant to those of us living in Los Angeles. After all, Markle grew up in the City of Angels and spent her childhood in Hollywood. Her father was a cinematographer on the TV sitcom, “Married… with Children.”

L.A. Times columnist and royal expert Patt Morrison joins Larry to talk about the royal wedding -- and the L.A. connection.

With AP files.

Guest:

Patt Morrison, author of “Don't Stop the Presses!: Truth, Justice, and the American Newspaper” (Angel City Press, 2018); columnist with the Los Angeles Times; she tweets

FilmWeek: ‘Deadpool 2,’ ‘Book Club,’ ‘First Reformed’ and more

Listen 38:51
FilmWeek: ‘Deadpool 2,’ ‘Book Club,’ ‘First Reformed’ and more

Larry Mantle and KPCC film critics Christy Lemire and Peter Rainer review this weekend’s new movie releases.

CRITICS' HITS

Christy: "Deadpool 2" & "Filmworker"

https://www.youtube.com/watch?v=D86RtevtfrA&t=94s

https://www.youtube.com/watch?v=PEZ2r1YGKSA

Peter: "First Reformed" & "On Chesil Beach" 

https://www.youtube.com/watch?v=hCF5Y8dQpR4

https://www.youtube.com/watch?v=nRRBajXoN4M

MIXED FEELINGS

Peter: "Pope Francis - A Man of His Word" 

https://www.youtube.com/watch?v=MOmY8i-uBcY

MISSES

Christy: "Cargo" & "Show Dogs"

https://www.youtube.com/watch?v=W5QJW0M5pik

https://www.youtube.com/watch?v=eT9eWtb7C4c

Peter: "Book Club" & "Dark Crimes"

https://www.youtube.com/watch?v=LDxgPIsv6sY

https://www.youtube.com/watch?v=5WWC0GTP08w

Guests:

Christy Lemire, film critic for KPCC, RogerEbert.com and co-host of YouTube’s “What the Flick?”; she tweets

Peter Rainer, film critic for KPCC and the Christian Science Monitor

Los Angeles Times & KPCC film critic Justin Chang on what you should be watching for coming out of the 2018 Cannes Film Festival

Listen 8:58
Los Angeles Times & KPCC film critic Justin Chang on what you should be watching for coming out of the 2018 Cannes Film Festival

It may be getting more attention for eschewing Netflix films or who is and isn’t wearing heels, but at the end of the day, the Cannes Film Festival in France is still all about le cinéma.

The famous French film festival is in its 71st year and wraps up this Saturday with a screening of the adventure comedy “The Man Who Killed Don Quixote” from director Terry Gilliam of Monty Python fame. It opened last Tuesday, May 8th with the film “Everybody Knows” from Iranian director Asghar Farhadi, a two-time Oscar winner for Best Foreign Language Film for “The Salesman” in 2017 and “A Separation” in 2012. Other films getting buzz include Spike Lee’s latest film “BlacKkKlansman,” the story of an African-American cop who infiltrates a local KKK chapter and “The House That Jack Built,” a murder thriller from director Lars Von Trier, just to name a couple.

KPCC and Los Angeles Times film critic Justin Chang has been in Cannes taking it all in. He joins Larry to talk about the major headlines from the festival, the movies he’s seen, frontrunners for the coveted Palme d’Or, and what you should be watching for as the films make their way to theaters in the U.S.

Guest:

Justin Chang, film critic for KPCC and the Los Angeles Times; he tweets